Find catalysts by drug or ticker
Filter by a partial drug name, ticker list, announcement dates, or target dates. Indication and clinical phase can be reviewed within the returned records, but they are not direct search filters.
Finance Agent capability
Research Reported Drug and Biotech Catalysts
Pineify Finance Agent organizes FDA-related market catalyst records by drug, ticker, indication, development phase, event type, target date, and source coverage. Use the calendar to find biotech events worth researching and to connect a catalyst with the company context, while treating dates and outcomes as reported evidence that must be verified.
Opens Finance Agent with an FDA catalyst-calendar question ready to send.
A research queue for biotech catalysts
See the drug, indication, phase, and target date together before opening the source
Search by drug name or one or more tickers, and distinguish announcement-date filters from target-date filters. The tool requests 20 records by default, supports up to 50, and may cache results for one hour. It preserves the returned order; a broad search is not guaranteed to show the nearest upcoming events.
A calendar record is not a guarantee of approval, trial success, or a current event. Dates can be estimates, historical records can remain in coverage, and the source may describe a presentation rather than an FDA decision. Verify the original announcement and latest company disclosure.
Use cases
Ways to use the FDA catalyst calendar
See development context
Keep phase, event type, target date, options availability, and market-cap context together when triaging an event.
Open the source behind the record
Follow source links to confirm what was announced, what remains uncertain, and whether the event is still actionable.
Prompt examples
FDA-calendar questions you can ask Finance Agent
“Find FDA-related catalysts for biotech tickers I specify. Group them by target date and phase, explain the event type, and link the source announcement without predicting the outcome.”“Search catalyst records for a named drug within an explicit target-date range. Review the indications in the returned records, separate historical events, and list the clinical or regulatory evidence to verify.”“Retrieve catalysts for my ticker list and target-date range, then identify Phase 2 and Phase 3 entries among the returned records. Flag incomplete coverage and uncertain target dates.”
FAQ
Questions about the FDA catalyst calendar
Available records include a drug, indication, ticker, event type, development phase, target date, status or outcome context, market information, and a source link.
Not always. It may refer to a company milestone, data presentation, trial update, or estimated catalyst. Read the source record to understand the event.
Coverage can include historical catalyst records for context. Filter by dates and verify the latest status before treating a record as actionable.
No. It organizes reported events. Clinical evidence, regulatory review, safety, and commercial factors determine outcomes.
Confirm the drug and indication in the source announcement, then consult trial records and current company disclosures. For an approval claim, check the applicable FDA approval record, such as Drugs@FDA, rather than inferring approval from a presentation or calendar badge.
No. They provide market context only. They do not measure clinical probability, approval odds, or the expected price reaction.
Check the evidence behind a catalyst date
Use the calendar to build a watchlist, then read the source announcement, clinical context, regulatory status, and company disclosures before making a decision.
Open Finance AgentFor informational and research use only. No output is investment advice or a guarantee of future performance.